Francesco Raspagliesi

ORCID: 0000-0001-8953-1657
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Endometrial and Cervical Cancer Treatments
  • Ovarian cancer diagnosis and treatment
  • Cervical Cancer and HPV Research
  • Uterine Myomas and Treatments
  • Endometriosis Research and Treatment
  • Intraperitoneal and Appendiceal Malignancies
  • Sarcoma Diagnosis and Treatment
  • PARP inhibition in cancer therapy
  • Renal cell carcinoma treatment
  • Genital Health and Disease
  • Gynecological conditions and treatments
  • Colorectal and Anal Carcinomas
  • Cancer-related molecular mechanisms research
  • Radiomics and Machine Learning in Medical Imaging
  • COVID-19 and healthcare impacts
  • Cancer Genomics and Diagnostics
  • Reproductive Biology and Fertility
  • Cancer Risks and Factors
  • Lymphoma Diagnosis and Treatment
  • Cancer Immunotherapy and Biomarkers
  • Estrogen and related hormone effects
  • Genetic factors in colorectal cancer
  • BRCA gene mutations in cancer
  • Immunotherapy and Immune Responses
  • Cancer Mechanisms and Therapy

Fondazione IRCCS Istituto Nazionale dei Tumori
2016-2025

Istituti di Ricovero e Cura a Carattere Scientifico
2014-2024

Clinica Universidad de Navarra
2024

University of Milan
2002-2024

Agostino Gemelli University Polyclinic
2024

European Institute of Oncology
2024

Sapienza University of Rome
2023

Innsbruck Medical University
2023

Universität Innsbruck
2023

Saitama Medical University
2022

Pelvic lymph nodes are the most common site of extrauterine tumor spread in early-stage endometrial cancer, but clinical impact lymphadenectomy has not been addressed randomized studies. We conducted a trial to determine whether addition pelvic systematic standard hysterectomy with bilateral salpingo-oophorectomy improves overall and disease-free survival. From October 1, 1996, through March 31, 2006, 514 eligible patients preoperative International Federation Gynecology Obstetrics stage I...

10.1093/jnci/djn397 article EN JNCI Journal of the National Cancer Institute 2008-11-25

Dostarlimab is an immune-checkpoint inhibitor that targets the programmed cell death 1 receptor. The combination of chemotherapy and immunotherapy may have synergistic effects in treatment endometrial cancer.We conducted a phase 3, global, double-blind, randomized, placebo-controlled trial. Eligible patients with primary advanced stage III or IV first recurrent cancer were randomly assigned 1:1 ratio to receive either dostarlimab (500 mg) placebo, plus carboplatin (area under...

10.1056/nejmoa2216334 article EN New England Journal of Medicine 2023-03-27

Background Despite significant advances in the screening, detection, and treatment of preinvasive cervical lesions, invasive cancer is fifth most common European women. There are large disparities Europe worldwide incidence, management, mortality cancer. Objective The Society Gynaecological Oncology (ESGO), for Radiotherapy (ESTRO), Pathology (ESP) jointly develop clinically relevant evidence-based guidelines order to improve quality care women with across worldwide. Methods ESGO/ESTRO/ESP...

10.1097/igc.0000000000001216 article EN cc-by-nc-nd International Journal of Gynecological Cancer 2018-04-24
Luis Chiva Vanna Zanagnolo Denis Querleu Nerea Martín‐Calvo Juan Arévalo‐Serrano and 95 more Mihai Emil Căpîlna Anna Fagotti Ali Kucukmetin Constantijne H. Mom G Chakalova Shamistan Aliyev Mario Malzoni Fabrice Narducci Octavio Arencibia Francesco Raspagliesi Tayfun Toptaş David Cibula Dilyara Kaidarova Mehmet Mutlu Meydanlı Mariana Vide Tavares Dmytro Golub Anna Myriam Perrone Ròbert Póka Dimitrios Tsolakidis Goran Vujić Marcin Jędryka Petra L.M. Zusterzeel Jogchum Jan Beltman Frédéric Goffin Dimitrios Haidopoulos Herman Haller Robert Jach Iryna Yezhova Igor Berlev Margarida Bernardino Rasiah Bharathan Maximilian Lanner Minna M Mäenpää Vladyslav Sukhin Jean‐Guillaume Feron Robert Fruscio Kersti Kukk Jordi Ponce José Ángel Mínguez Daniel Vázquez-Vicente Teresa Castellanos Enrique Chacón Juan Luis Alcázar Nabil Abdalla Özgür Akbayır Sedat Akgöl Elif Akşahin Shamistan Aliyev María Alonso-Espías Игор Алулоски Cláudia Regina Furquim de Andrade Nikola Badzakov Rosa Barrachina Giorgio Bogani Eduard-Aexandru Bonci Hélène Bonsang‐Kitzis Félix Boria Cosima Brucker L. M. Cardenas Andrea Casajuana Pere Cavallé Jorge Cea Benito Chiofalo Gloria Cordeiro Pluvio Coronado María Cuadra Javier Dı́ez Teresa Diniz da Costa Santiago Domingo Lukáš Dostálek Fuat Demirkiran Diego Erasun Mathias K. Fehr Sergi Fernández-González Annamaria Ferrero Soledad Fidalgo Gabriel Fiol Khadra Galaal José Alenza García Gerhard Gebauer Fabio Ghezzi Juan Gilabert–Estellés Nana Gomes Elisabete Gonçalves Virginia González Frédéric Grandjean Miriam Guijarro Frédéric Guyon Jolien Haesen Ginés Hernández-Cortes Sofía Herrero Imre Pete Ioannis Kalogiannidis Erbil Karaman Andreas Kavallaris

Minimally invasive surgery in cervical cancer has demonstrated recent publications worse outcomes than open surgery. The primary objective of the SUCCOR study, a European, multicenter, retrospective, observational cohort study was to evaluate disease-free survival patients with stage IB1 (FIGO 2009) undergoing vs minimally radical hysterectomy. As secondary objective, we aimed investigate association between protective surgical maneuvers and risk relapse. We obtained data from 1272 that...

10.1136/ijgc-2020-001506 article EN cc-by-nc-nd International Journal of Gynecological Cancer 2020-08-12

6000 Background: The role of secondary cytoreductive surgery in recurrent ovarian cancer (ROC) has been under debate for decades. A recent trial unselected patients (pts) failed to show an OS benefit. Methods: Pts with ROC and 1st relapse after 6+ months (mos) platinum-free interval (TFIp) were eligible if they presented a positive AGO-score (PS ECOG 0, ascites ≤500 ml, complete resection at initial surgery) prospectively randomized second-line chemotherapy alone vs. followed by the same...

10.1200/jco.2020.38.15_suppl.6000 article EN Journal of Clinical Oncology 2020-05-20

To evaluate how the duration of human papillomavirus (HPV) persistence influences risk developing recurrent high-grade cervical dysplasia (CIN2+).Data patients with persistent HPV infection (at least at 6 months) after primary conization were extracted from a multi-institutional Italian database, retrospectively. Kaplan-Meier and Cox proportional hazards models used to associations between 5-year CIN2+.Overall, 545 met inclusion criteria. Positive margins detected in 160 (29.3%) patients....

10.1097/cej.0000000000000822 article EN European Journal of Cancer Prevention 2023-07-03

The objective of this work is to assess the 5-year outcomes patients undergoing conization for high-grade cervical lesions that simultaneously present as risk factors in persistence HPV infection and positivity surgical resection margins. This a retrospective study evaluating lesions. All included had both positive margins experienced at 6 months. Associations were evaluated with Cox proportional hazard regression summarized using ratio (HR). charts 2966 reviewed. Among whole population, 163...

10.3390/vaccines11030698 article EN cc-by Vaccines 2023-03-18

Human papillomavirus (HPV) is the primary cause of cervical dysplasia and cancer. Attempts are needed to better categorize patients with HPV in order provide useful information for prognosticating appropriately tailoring surveillance.

10.1002/cncy.22760 article EN Cancer Cytopathology 2023-09-25

Objective: To date, no data supports the execution of vaccination after hysterectomy for high-grade cervical intraepithelial neoplasia (CIN2+) and early-stage cancer. We aim to evaluate potential effect Methods: This is a multi-center retrospective study evaluating women who develop lower genital tract dysplasia (including anal, vulvar vaginal intra-epithelial neoplasia) having CIN2+ FIGO stage IA1- IB1 Results: Overall, charts 77 patients developed were collected. The population included 62...

10.1177/03008916231208344 article EN Tumori Journal 2023-11-17

Endometriosis is a benign, chronic, inflammatory condition affecting up to 10 % of women and characterised by the presence glands stroma tissue outside uterus. Epidemiological clinical studies demonstrate consistent association between endometriosis infertility. However, this relationship far be clearly understood several mechanisms are involved. Available data show that patients with have an increased estimated risk infertility two four times compared general population. On other hand,...

10.1016/j.bpobgyn.2023.102454 article EN Best Practice & Research Clinical Obstetrics & Gynaecology 2024-01-03
Coming Soon ...